Check a product
Search or scan any product against every CPSC, FDA, USDA, and NHTSA recall on record — or read the last 90 days below.
- 2026-06-24FDA-FoodGREENWORLD FOOD EXPRESS (USA) LLCClass IAl Yaman Halawa Extra Pistachio recalled for Salmonella risk
Al Yaman Halawa Extra Pistachio spread in 907g plastic jars may be contaminated with Salmonella. The contamination was identified in Lot 13286, distributed in Michigan and New York. A total of 18 retail units are affected.
- 2026-06-24FDA-FoodUnited States BakeryClass IIGreat Value Hawaiian Rolls recalled for packaging contamination
Great Value Hawaiian Roll 4-packs were found to have an oily and sticky substance on the food-contact surface of the packaging. The affected product was identified at wholesale distribution centers before reaching store shelves, and all units have been accounted for.
- 2026-06-24FDA-FoodNutrisystem IncClass IINutrisystem Chocolate Cheesecake recalled for undeclared soy
Nutrisystem Chocolate Cheesecake 2 oz frozen packages contain soy that is not declared on the label. People with a soy allergy who eat this product could have an allergic reaction. The recall affects 5,184 units with lot code CH030426 distributed across 25 states.
- 2026-06-24FDA-FoodMID DOLCIARIA SRLClass IIMid Dolciaria cannoli recalled for unapproved food coloring
Mid Dolciaria .155 Crunchy Cannoli Gluten Free desserts contain chlorophyll colors (E140 and E141) that are not approved for use in the United States. The affected lot was distributed in the USA.
- 2026-06-24FDA-FoodMID DOLCIARIA SRLClass IIMid Dolciaria Cannoli Siciliani recalled for unapproved colors
Mid Dolciaria Cannoli Siciliani dessert boxes contain unapproved food colorings (chlorophyll E140 and E141) that are not permitted in the U.S. The affected product was distributed in the USA with a best-before date of 10/17/2026.
- 2026-06-24FDA-DrugDabur India LimitedClass IIMed Pride Triple Antibiotic Ointment recalled for manufacturing deficiencies
The FDA identified manufacturing deficiencies during inspection of Med Pride Triple Antibiotic Ointment (1oz tubes). Multiple lots do not meet required manufacturing standards. No injuries have been reported.
- 2026-06-24FDA-DrugDabur India LimitedClass IIMed Pride Triple Antibiotic Ointment recalled for quality deficiencies
Med Pride Triple Antibiotic Ointment packets were found to have manufacturing quality deficiencies during an FDA inspection. The affected lots do not meet federal quality standards, though no injuries have been reported.
- 2026-06-24FDA-DrugDabur India LimitedClass IIMed Pride Hydrocortisone Cream recalled for manufacturing deficiencies
The FDA found manufacturing deficiencies during an inspection of the facility that produces Med Pride Hydrocortisone Cream 1%. These deviations from proper manufacturing standards affected multiple lots of the product currently still within their expiration dates.
- 2026-06-24FDA-DrugDabur India LimitedClass IIMed Pride Hydrocortisone Cream recalled for quality deficiencies
The FDA found manufacturing quality control problems (CGMP deviations) during an inspection of the facility that makes Med Pride Hydrocortisone Cream 1%. Multiple lots of the product are affected. No injuries have been reported.
- 2026-06-24FDA-DrugDabur India LimitedClass IIMed Pride antifungal cream recalled for manufacturing deficiencies
The FDA found manufacturing deficiencies during an inspection of Med Pride 1% Clotrimazole Antifungal Cream. These deficiencies do not meet federal good manufacturing practice standards. About 5,755 tubes across multiple lots are affected.
- 2026-06-24FDA-DrugDabur India LimitedClass IIMed Pride Bacitracin Zinc Ointment recalled for manufacturing deficiencies
The FDA found manufacturing deficiencies during an inspection of the facility that made Med Pride Bacitracin Zinc Ointment. This affects specific batches (Lot #022, 023, and 024) distributed nationwide.
- 2026-06-24FDA-DrugDabur India LimitedClass IIMed Pride Bacitracin Zinc Ointment recalled for manufacturing deficiencies
The FDA found manufacturing quality control problems during an inspection of the facility that produced Med Pride Bacitracin Zinc Ointment. This ointment is used to help prevent infection in minor cuts and scrapes. The affected batches were distributed nationwide.
- 2026-06-24FDA-DrugDabur India LimitedClass IIMed Pride Bacitracin Zinc Ointment recalled for manufacturing deficiencies
The FDA identified manufacturing quality control problems during an inspection of the facility that produces Med Pride Bacitracin Zinc Ointment. Certain lot numbers do not meet federal manufacturing standards for sterile wound-care products.
- 2026-06-24FDA-DrugDabur India LimitedClass IICura Hongos antifungal cream recalled for manufacturing deficiencies
Dabur India Limited's Cura Hongos antifungal cream (clotrimazole 1%, 2oz tubes) was found to have manufacturing deficiencies during an FDA inspection. The affected product (Lot #0003) does not meet U.S. manufacturing standards. No injuries have been reported.
- 2026-06-24FDA-DrugDabur India LimitedClass IIRapidol Triple Antibiotic ointment recalled for manufacturing deficiencies
The FDA found manufacturing deficiencies during an inspection of the facility that made Rapidol Triple Antibiotic First Aid Ointment. The product does not meet federal manufacturing standards. About 84 tubes (Lot 0004) were distributed nationwide.
- 2026-06-24FDA-DrugDabur India LimitedClass IILil Drug Store Triple Antibiotic Ointment recalled for manufacturing deficiencies
The FDA identified manufacturing deficiencies during an inspection of this triple antibiotic ointment product. The affected lot (0005) is still within its expiration date. No injuries have been reported.
- 2026-06-24FDA-DrugDabur India LimitedClass IICircle K triple antibiotic ointment recalled for manufacturing issues
Circle K triple antibiotic ointment tubes manufactured by Dabur India Limited have been recalled due to deficiencies found during an FDA inspection. The affected lots (0001 and 0005) do not meet current manufacturing standards for sterile products.
- 2026-06-24FDA-DrugDabur India LimitedClass IILucky Super Soft antibiotic ointment recalled for manufacturing deficiencies
The FDA inspected the manufacturer of Lucky Super Soft First Aid Triple Antibiotic Ointment and found deficiencies in how the product was made and quality-controlled. The affected tubes are lot numbers 0002 and 0003, which are still within their expiration dates.
- 2026-06-24FDA-DrugDabur India LimitedClass IILucky Super Soft antifungal cream recalled for manufacturing deficiencies
Dabur India Limited's Lucky Super Soft Antifungal Athlete's Foot Cream (Clotrimazole 1%, 1.5 oz tubes) is being recalled due to manufacturing deficiencies found during an FDA inspection. The affected lots (0001 and 0002) were distributed nationwide.
- 2026-06-24FDA-DrugInventia Healthcare LimitedClass IIInventia Healthcare chlorthalidone tablets recalled for dissolution failure
Inventia Healthcare Limited's chlorthalidone 25 mg tablets failed to meet dissolution specifications, meaning the tablets may not break down properly in the body and deliver the full dose. This affects 100-tablet and 1000-tablet bottles distributed nationwide. No injuries have been reported.
- 2026-06-24FDA-DrugSandoz IncClass IIISandoz Focalin XR 5 mg recalled for labeling error
Sandoz is recalling one lot of Focalin XR (dexmethylphenidate HCl) 5 mg extended-release capsules because some bottles have incorrect or missing lot numbers and expiration dates on the label. The affected lot (VA0099422) was distributed nationwide. This is a labeling issue only; the medication itself has not been found to be unsafe.
- 2026-06-24FDA-DrugKeystone IndustriesClass IISafco SensiCaine-Ultra topical anesthetic recalled for defective seals
Safco SensiCaine-Ultra topical anesthetic gel bottles may have incomplete seals, which could allow the product to leak or become contaminated. This affects 150 units distributed nationwide. No injuries have been reported.
- 2026-06-24FDA-DrugKeystone IndustriesClass IIPureLife benzocaine gel recalled for defective bottle seals
PureLife topical anesthetic gel (benzocaine 20%, 1 oz) may contain bottles with incomplete seals. This could allow the product to leak or become contaminated. About 450 units were distributed nationwide.
- 2026-06-24FDA-DrugKeystone IndustriesClass IIDental City benzocaine gel recalled for defective container seals
Dental City topical anesthetic gel (benzocaine 20%, strawberry flavor) may contain bottles with incomplete seals. This defect could allow the product to leak or become contaminated. The recall affects 450 units distributed nationwide.
- 2026-06-24FDA-DrugKeystone IndustriesClass IIBurkhart benzocaine gel recalled for incomplete bottle seals
Burkhart topical anesthetic gel (benzocaine 20%, strawberry flavor) may contain bottles with incomplete seals, which could allow the product to leak or become contaminated. About 150 units with expiration date 04/15/2029 are affected nationwide.
- 2026-06-24FDA-DrugKeystone IndustriesClass IIDHP Topical Anesthetic Gel recalled for incomplete bottle seals
DHP Topical Anesthetic Gel (Benzocaine 20%, Strawberry Flavor) may contain bottles with incomplete seals that could compromise the integrity of the product. About 150 units with lot number BNZ-001921 and expiration date April 15, 2029 were distributed nationwide.
- 2026-06-24FDA-DrugKeystone IndustriesClass IIQuala topical anesthetic gel recalled for incomplete seals
Quala Dental Products topical anesthetic gel (20% benzocaine, strawberry flavor, 1 oz bottles) may have incomplete seals on some bottles. This could allow the product to leak or become contaminated. The recall affects 150 units distributed nationwide.
- 2026-06-24FDA-DrugKeystone IndustriesClass IIPearson Quality benzocaine gel recalled for defective seals
Pearson Quality Topical Anesthetic Gel (20% benzocaine, mint flavor) may contain bottles with incomplete seals. The defective containers could allow the product to leak or become contaminated. About 900 units are affected nationwide.
- 2026-06-24FDA-DrugPar Health USA, LLCClass IIPar Health USA buprenorphine injection recalled for crystallization
Par Health USA's buprenorphine HCl injection (0.3 mg/mL) has been found to contain crystallization identified as buprenorphine free base in certain lots. This affects vials distributed nationwide. The FDA has classified this as a Class II recall.
- 2026-06-24FDA-DrugAjanta Pharma USA IncClass IIAjanta Pharma aripiprazole recalled for wrong medication inside bottle
Ajanta Pharma USA Inc. distributed bottles labeled as Aripiprazole 30 mg that actually contained Voriconazole 50 mg, a different medication used to treat fungal infections. This mix-up affected 6,143 bottles (Lot PA00805, expiring 01/31/2029) distributed nationwide. The error was discovered and reported to the FDA.